NACL Industries Ltd

NACL Industries has postponed the meeting of the Board of Directors which was scheduled to be held on 14 May 2025. The meeting will now be held on a later date.Powered by Capital Market - Live

NACL Industries will hold a meeting of the Board of Directors of the Company on 14 May 2025.Powered by Capital Market - Live

Shares of NACL Industries surged 110.7% in fifteen trading sessions from its recent closing low of Rs 99.50 on 26 March 2025. The counter touched a record high of Rs 209.65 today and has skyrocketed 331.38% from its 52-week low of Rs 48.60 recorded on 26 November 2024. On the BSE, 1.22 lakh shares have been traded so far, compared with average daily volumes of 4.26 lakh shares in the past two weeks. The stock had outperformed the market over the past month, rising 102.85% as against the Sensex's 4.25% rise. The scrip had outperformed the market in the past three months, jumping 211.33% as against a 3.27% drop in Sensex. The counter had also outperformed the market in the past year, soaring 237.33% as against Sensex's 8.9% jump. On the technical front, the stock's daily RSI (relative strength index) stood at 93.147. The RSI oscillates between zero and 100. Traditionally, the RSI is considered overbought when above 70 and oversold when below 30. On the daily chart, the stock was trading above its 50-day, 100-day, and 200-day simple moving average (SMA), placed at 97.55, 79.82, and 69.09, respectively. These levels will act as crucial support zones in the near term. NACL Industries is engaged in the business of crop protection and manufactures both technicals (active ingredients) and formulations. The company reported a consolidated net loss of Rs 36.23 crore in Q3 FY25, compared with a net loss of Rs 15.90 crore in Q3 FY24. Revenue from operations declined 26.7% YoY to Rs 267.77 crore in Q3 FY25.Powered by Capital Market - Live

Shares of NACL Industries surged 57.34% in nine trading sessions from its recent closing low of Rs 99.50 on 26 March 2025. The stock hit a 52-week high of Rs 29.84 today. The counter has soared 222.12% from its 52-week low of Rs 48.60 hit on 26 November 2024. On the BSE, 0.33 lakh shares have been traded so far, compared with average daily volumes of 2.26 lakh shares in the past two weeks. The stock had outperformed the market over the past month, rising 132.27% as against the Sensex's 0.35% shed. The scrip had outperformed the market in the past three months, jumping 135.45% as against a 4.56% drop in Sensex. The counter had also outperformed the market in the past year, soaring 148.3% as against Sensex's 1.58% decrease. On the technical front, the stock's daily RSI (relative strength index) stood at 86.553. The RSI oscillates between zero and 100. Traditionally, the RSI is considered overbought when above 70 and oversold when below 30. On the daily chart, the stock was trading above its 50-day, 100-day, and 200-day simple moving average (SMA), placed at 83.40, 71.69, and 65.77, respectively. These levels will act as crucial support zones in the near term. NACL Industries is engaged in the business of crop protection and manufactures both Technicals (Active Ingredient) and Formulations. The company reported a consolidated net loss of Rs 36.23 crore in Q3 FY25, compared with net loss of Rs 15.90 crore in Q3 FY24. Revenue from operations declined 26.7% YoY to Rs 267.77 crore in Q3 FY25.Powered by Capital Market - Live

Barak Valley Cements Ltd, Pasupati Acrylon Ltd, Deccan Health Care Ltd and Natural Capsules Ltd are among the other losers in the BSE's 'B' group today, 18 March 2025.NACL Industries Ltd lost 9.99% to Rs 99.72 at 14:33 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 2.65 lakh shares were traded on the counter so far as against the average daily volumes of 1.21 lakh shares in the past one month.Barak Valley Cements Ltd crashed 7.90% to Rs 40.7. The stock was the second biggest loser in 'B' group.On the BSE, 4718 shares were traded on the counter so far as against the average daily volumes of 3680 shares in the past one month.Pasupati Acrylon Ltd tumbled 6.65% to Rs 53.63. The stock was the third biggest loser in 'B' group.On the BSE, 18958 shares were traded on the counter so far as against the average daily volumes of 27433 shares in the past one month.Deccan Health Care Ltd corrected 6.59% to Rs 17. The stock was the fourth biggest loser in 'B' group.On the BSE, 1.7 lakh shares were traded on the counter so far as against the average daily volumes of 56501 shares in the past one month.Natural Capsules Ltd slipped 6.10% to Rs 184. The stock was the fifth biggest loser in 'B' group.On the BSE, 2698 shares were traded on the counter so far as against the average daily volumes of 4645 shares in the past one month.Powered by Capital Market - Live

The Board of NACL Industries at its meeting held on 12 March 2025 has approved the following: 1. Appointment of G V Bhadram as Whole-Time Director 2. Resignation of M Pavan Kumar as Managing Director and CEO 3. Resignation of C V Rajulu as Non-Executive and Non -Independent DirectorPowered by Capital Market - Live

Net Loss of NACL Industries reported to Rs 36.23 crore in the quarter ended December 2024 as against net loss of Rs 15.90 crore during the previous quarter ended December 2023. Sales declined 26.72% to Rs 267.77 crore in the quarter ended December 2024 as against Rs 365.40 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales267.77365.40 -27 OPM %-9.751.12 - PBDT-39.59-13.37 -196 PBT-46.72-20.30 -130 NP-36.23-15.90 -128 Powered by Capital Market - Live

NACL Industries will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live

NACL Industries announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 9 January 2025.Powered by Capital Market - Live

The Board of NACL Industries at its meeting held on 12 December 2024 has approved the allotment of 68,96,550 warrants at an issue price of Rs 58 per warrant aggregating to Rs 39.99 crore on preferential basis to the promoter of the company. The Board also approved the allotment of 17,24,137 equity shares at an issue price of Rs 58 per share aggregating to Rs 9.99 crore on a preferential basis to a non-promoter entity. Powered by Capital Market - Live